CNET reports:
Using the same mRNA technology that broke the mold with effective COVID-19 vaccines, Moderna has developed two vaccines for HIV. The first phase of testing for both could begin as early as Thursday, according to a post on the National Institutes of Health website for clinical trials. Phase 1 of the vaccine trial will test the vaccines’ safety, as well as measure immunity and antibody responses. If the vaccines prove to be safe, they’ll need to go through additional testing for researchers to determine how effective they are…
There were 37.7 million people living with HIV globally in 2020, according to United Nations data.
“There’s a pressing need for new ways to prevent infection from viruses like HIV and influenza that conventional vaccines have struggled to address and to treat rare genetic diseases and cancers that kill millions each year,” writes a reporter at Axios. “Vaccines and therapies based on messenger RNA hold promise as a solution.”
of this story at Slashdot.
Source:: Slashdot